FLGR-242

Biochemical Profile and Overview of FLGR-242

FLGR-242 is a specialized research compound engineered to isolate the functional binding domains of follistatin-like proteins. In molecular biology literature, follistatin and its derived sequences are classified as endogenous glycoproteins capable of neutralizing specific ligands within the transforming growth factor-beta (TGF-β) superfamily. FLGR-242 was designed to replicate the primary binding motifs responsible for ligand interaction without carrying the non-essential structural sequences found in native full-length proteins.

Researchers utilizing FLGR-242 target its specific affinity for myostatin (GDF-8) and activin A. Because the full-length follistatin protein contains multiple domain structures that interact with a broad spectrum of signaling molecules, synthetic fragments like FLGR-242 provide laboratory investigators with a refined tool to examine isolated receptor-ligand interactions. This targeted specificity reduces confounding bioactivity in controlled cell culture and tissue model assays.

At PX1 Research, FLGR-242 is manufactured under strict quality standards within US-based facilities. Each 20mg vial contains a highly stable, lyophilized cake intended strictly for reconstitutive laboratory experimentation. Researchers exploring protein-protein interaction networks can review detailed molecular specifications within our research library hub or evaluate comparative peptides across our full research peptides catalog.

Mechanism of Action: Myostatin and Activin Neutralization

The primary mechanism of action associated with FLGR-242 involves its stoichiometric binding to circulating member proteins of the TGF-β superfamily. Preclinical models indicate that myostatin functions as a negative regulator of skeletal muscle mass by activating the Activin Type IIB receptor (ActRIIB) signaling cascade. Upon receptor binding, myostatin initiates intracellular Smad2/3 phosphorylation, which downregulates transcriptional pathways involved in protein synthesis.

In vitro binding assays demonstrate that FLGR-242 acts as a competitive antagonist by sequestering myostatin ligands before they engage cell-surface ActRIIB complexes. By blocking ligand-receptor coupling, FLGR-242 prevents downstream Smad signal transduction. Laboratory evaluations show that this inhibition alters normal regulatory feedback loops, providing a framework for studying hyper-trophic cellular pathways in myoblast cultures.

In addition to myostatin sequestration, FLGR-242 exhibits high affinity for activin A. Activin signaling participates in various cellular processes including differentiation, inflammation, and cellular senescence. By providing a stable, high-affinity decoy fragment, FLGR-242 allows researchers to analyze how selective ligand deprivation impacts gene expression profiles in mammalian cell lines.

Preclinical Applications in Skeletal Muscle and Tissue Models

In vitro studies involving skeletal muscle cell lines (such as C2C12 myoblasts) frequently utilize FLGR-242 to evaluate myotube differentiation and protein turnover rates. When myostatin-mediated signaling is attenuated by FLGR-242 in culture media, researchers observe measurable increases in myotube diameter, elevated fusion indices, and altered expression of structural proteins like myosin heavy chain (MHC).

Animal study models investigating muscle wasting, sarcopenia, and cachexia also incorporate myostatin inhibitors to assess functional outcomes in tissue architecture. Experimental protocols involving murine models have examined how targeted administration of follistatin derivatives influences fiber cross-sectional area (CSA) and satellite cell activation. FLGR-242 serves as an essential probe compound for identifying whether localized inhibition of myostatin can preserve lean tissue mass under catabolic stress conditions.

Furthermore, researchers exploring extracellular matrix (ECM) remodeling and fibrosis study FLGR-242 due to its overlap with broader TGF-β pathway dynamics. Because TGF-β signaling is intricately tied to collagen deposition and fibrotic tissue conversion, utilizing FLGR-242 allows laboratories to map out complex signaling cross-talk between structural growth factors and cellular repair mechanisms. For researchers managing larger experimental designs, PX1 Research provides volume options through our dedicated wholesale program.

Comparative Analysis: FLGR-242 vs. Follistatin-344 and ACE-031

When evaluating myostatin-inhibiting compounds for preclinical study, researchers frequently compare FLGR-242 against other key regulators in the pathway. Understanding the structural and operational differences between these molecules is vital for designing precise experimental controls.

Follistatin-344 is a full-length isoform containing 344 amino acids. While highly effective at binding myostatin and activin, follistatin-344 presents broader biological interactions due to its heparin-binding domain, which can cause non-specific cell surface attachment. In contrast, FLGR-242 is a truncated, optimized peptide sequence that reduces non-specific binding while maintaining target affinity for GDF-8.

Another widely studied baseline compound is ace-031, a soluble fusion protein consisting of the extracellular domain of the ActRIIB receptor linked to an Fc immunoglobulin fragment. While ACE-031 acts as a receptor decoy that binds a wide array of TGF-β ligands (including GDF-11 and BMPs), FLGR-242 exhibits a more focused target profile centered primarily on myostatin and activin A. Researchers investigating downstream anabolic pathways may also pair these studies with somatotropic axis agents such as igf-1-lr3 to analyze complementary signaling cascades.

Selecting between these research compounds depends entirely on the specificity required for the assay. FLGR-242 provides a targeted approach when non-specific TGF-β blockade or off-target extracellular binding would obscure experimental findings.

Analytical Purity and Quality Criteria at PX1 Research

Assay reproducibility in biomedical research relies strictly on compound purity, lot-to-lot consistency, and the complete absence of contaminants. PX1 Research adheres to rigorous quality control protocols for every batch of flgr-242 20mg manufactured for laboratory supply.

Our analytical testing process relies on two core verification techniques:

1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Ensures peptide purity exceeds 98%. RP-HPLC isolates the primary peptide peak from synthesis byproducts, truncated sequences, or residual reagents.

2. Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact molecular weight and amino acid composition, confirming that the synthesized peptide matches its theoretical mass spectrum.

In addition to structural verification, every lot undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing to confirm low endotoxin levels (<0.01 EU/mg). High endotoxin concentrations can introduce unwanted inflammatory responses in cell culture models, invalidating experimental data. PX1 Research includes a comprehensive, lot-specific Certificate of Analysis (COA) with every shipment to give researchers full transparency.

Laboratory Handling, Reconstitution, and Solution Preparation

FLGR-242 is delivered as a sterile, lyophilized (freeze-dried) powder containing 20mg of active peptide sequence. To maintain structural stability during reconstitution, researchers should adhere to standard laboratory protocols for peptide handling.

Reconstitution Procedures:

• Solvents: Use sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile deionized water, depending on the requirements of your specific assay system.

• Technique: Introduce the reconstituting solvent down the inner glass wall of the vial to prevent turbulent disruption of the peptide cake. Gentle swirling is recommended; never vortex or vigorously shake the solution, as mechanical shear stress can disrupt secondary peptide structures.

• Concentration Setup: Adding 2.0 mL of sterile solvent to the 20mg vial yields a stock concentration of 10 mg/mL, simplifying aliquot measurements for microplate assays.

For additional technical documentation on solvent compatibility and molarity calculations, consult our dedicated guide on peptide reconstitution.

Storage Conditions and Lyophilized Stability

Proper storage conditions are critical for preserving the bioactivity and structural integrity of FLGR-242 over extended research timelines.

Lyophilized Powder Storage: Upon arrival at the laboratory, unopened vials of lyophilized FLGR-242 should be stored at -20°C for long-term stability (up to 24 months). If stored at standard refrigerated temperatures (2°C to 8°C), the un-reconstituted compound remains stable for up to 90 days. Keep vials protected from light exposure.

Reconstituted Solution Storage: Once dissolved, reconstituted liquid aliquots must be stored at 2°C to 8°C and utilized within 14 days. For long-term experimental protocols, divide the reconstituted stock into single-use aliquots and freeze at -80°C to avoid repeated freeze-thaw cycles, which degrade peptide bonds over time.

Detailed storage guidelines and degradation kinetics are indexed within our comprehensive peptide storage protocol.

USA Supply Infrastructure and Distribution

Timely procurement and consistent product sourcing are essential for maintaining uninterrupted research workflows. PX1 Research operates state-of-the-art manufacturing and fulfillment facilities based entirely in the United States, utilizing distribution nodes in California and Arizona.

Orders placed before 12:00 PM PST Monday through Friday are processed for same-day dispatch. By maintaining inventory directly within our domestic warehouses, we eliminate international transit delays, customs holds, and cold-chain degradations frequently associated with overseas peptide suppliers.

Every batch of flgr-242 20mg shipped from PX1 Research is backed by verified HPLC/MS documentation, temperature-controlled storage prior to shipping, and lot traceability. Researchers can establish institutional accounts or request custom lot reservations via our wholesale portal.